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Aims Despite catheter ablation (CA) has become an accepted treatment option for symptomatic, drug-resistant atrial fibrilla-
tion (AF), the safety of this procedure continues to be cause for concern. The aim of the present study was to assess the
incidence of complications with permanent sequelae of CA for AF using open-irrigated catheters in a contemporary,
unselected population of consecutive patients.
Methods
and results
From 1 January 2011 to 31 December 2011, data from 2167 consecutive patients who underwent CA for AF using an
open-irrigated catheter in 29 Italian centreswere collected. All the complicationsoccurring to the patient from admission
to the 30th post-procedural day were recorded. No procedure-related death was observed. Complications occurred in
81 patients (3.7%): 46 patients (2.1%) suffered vascular access complications; 13 patients (0.6%) cardiac tamponade, suc-
cessfully drained in all the cases; six patients (0.3%) arterial thromboembolism (four transient ischaemic attack and two
ischaemic strokes); five (0.2%) patients conservatively treated pericardial effusion; three patients (0.1%) phrenic nerve
paralysis; three patients (0.1%) pericarditis; three patients (0.1%) haemothorax, and two patients (0.1%) other isolated
adverse events. At multivariate analysis, only female sex [odds ratio (OR) 2.5, confidence interval (CI): 1.5–3.7, P, 001]
and the operator experience (OR 0.5, CI: 0.4–0.7, P, 001) related to the complications. Only five (0.2%) patients devel-
oped permanent sequelae from their complications.
Conclusion Catheter ablation for AF with the use of open-irrigated catheters is currently affected by a very low rate of complications
leading to permanent sequelae.
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Introduction
Catheter ablation (CA) of atrial fibrillation (AF) is a well-established
treatment option for recurrent, symptomatic, drug-resistant AF.1,2
Despite the satisfactory results justifying3 – 5 the recommendation
for CA by international guidelines in selected patients, the safety of
this procedure remains cause for concern.1,2,6 Previous studies
reported a rate of complications ranging from 3.5 to 6.3%.7– 12
These reports, however, gathered events with extremely different
outcomes: from groin haematomas requiring few days of rest to pul-
monary vein (PV) stenosis with pulmonary distress and thrombo-
embolic events leading to permanent disability. Only one study
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specifically focused on complications and reported prevalence and
causes of fatal outcome following CA of AF.13 Thus, the effect on
prognosis of complications recorded during CA for AF is unknown.
Open-irrigated catheters (OIC) are widely used for radiofrequency
CA14 in particular of AF.15–17 In fact, OIC overcome some limitations
of 4 and 8 mm radiofrequency catheter, such as coagulum formation
and insufficient power delivery in areas of low blood flow. However,
concern has been raised regarding the safety of OIC, especially when
used with high power, due to an increased occurrence of cardiovas-
cular and gastrointestinal complications.15
The aim of the present study was to assess the incidence of com-
plications with permanent sequelae of CA for AF using OIC in a con-
temporary population of consecutive patients.
Methods
Study population
We prospectively collected clinical and procedural data concerning con-
secutive patients who underwent CA for AF in 29 Italian electrophysi-
ology laboratories between 1 January and 31 December 2011.18 In
2167 of these patients, CA was performed by using an OIC and they
represented our study population. This observational study was
approved by the local institutional review committees, and written
informed consent was obtained from each patient.
Anticoagulation
Most of the patients were on oral anticoagulants (dicumarol or aceno-
coumarol) with a therapeutic international normalized ratio .2.0 for
at least 4 weeks preceding the procedure, or performed transoesopha-
geal echocardiographic assessment to exclude the presence of left
atrial thrombus. Oral anticoagulants were withdrawn 2 or 3 days
before ablation, and substituted with low-molecular-weight heparin
until 12 h before the procedure. Unfractionated heparin infusion was
started immediately after transseptal catheterization, to maintain the
mean activated clotting time (ACT) between 300 and 400 s.
Low-molecular-weight heparin was restarted 4–6 h after sheaths
removal, and continued until oral anticoagulant therapy started on the
same day of the procedure reached the therapeutic target.
Ablation
All ablation strategies aiming at isolating or encircling the PVs were
included in the Registry. Additional linear lesions in the right or left
atrium were also allowed. For the purpose of this study, we report data
only on CA procedures performed by means of OIC [Navistarw,
ThermoCoolw, or ThermoCool SFw (Biosense Webster Inc.) or Cool-
pathw or Cooflexw (St Jude Medical Inc. Endocardial Solutions)]. Radio-
frequency pulses were delivered with a temperature setting of 458C and
radiofrequency energy up to 50 W. In several centres, when ablation was
performed in the posterior wall of the left atrium, the radiofrequency
power was usually reduced to 25 W to avoid the risk of injuring the ad-
jacent structures. In the majority of centres, ablation was guided by a
three-dimensional non-fluoroscopic mapping system [CartoTM system
(Biosense Webster Inc.) or EnSite NavXTM (St Jude Medical Inc. Endocar-
dial Solutions)] creating an electroanatomical map of left atrium and PVs
with or without the integration of left atrial computed tomography or
magnetic resonance scans.
A circular mapping catheter was widely used to confirm PV’s electro-
physiological isolation and intracardiac echo imaging was used to guide
the PV antrum isolation in the two laboratories.
Definitions
Complications were defined as all unexpected events which required
intervention or prolonged hospital stay beyond the scheduled period.
Early tachyarrhythmias (AF or atrial tachycardia/flutter) were not
included even if requiring cardioversion.
Complications with permanent sequelaewere defined as those leading to
death or causing permanent harm not resolving within 30 days from CA.
Procedures were done by different operators. Personal background
as first operator was considered to classify the operator’s experience:
,100 procedures; between 101 and 500 procedures; and .500
procedures.
Data collection
The investigators were provided with the same data sheet for the collec-
tion of specific information on each ablation procedure. Data were col-
lected retrospectively by each investigator, and sent via a computerized
database in Excel format (Windows 7, XP, or Mac) to the coordinating
centre for analysis. Each author took responsibility for data integrity.
The Registry considered complications occurring from hospital admis-
sion of thepatient to the 30th post-procedural day. Complications occur-
ring after the hospital stay and clinical status of patients developing
complications were collected through outpatient visit or telephone
interview.
Statistical analysis
Normally distributed continuous variables were expressed as means
(SD) and compared with Student’s t-test. Normality was assessed using
the Shapiro–Wilk test. Skewed variables were expressed as medians
(quartiles) and compared with the rank-sum test. Categorical variables
were presented as counts and percentages, and compared with x2 or
Fisher’s exact test, as appropriate. A logistic regression model was
designed and stepwise backward selection was performed to identify sig-
nificant and independent predictors of complications. Independent vari-
ables were chosen when a P, 0.10 emerged at univariate analysis. The
startingmodel included: gender; age; and operator’s experience. A signifi-
cant increase in risk was obtained if the 95% confidence interval (CI)
exceeded 1 and the P value of the Wald test was ,0.05.
Analysis was performed by means of SPSS (version 11.0, SPSS Inc.).
Results
Clinical and procedural data
The final patient cohort included 2167 consecutive patients. Baseline
clinical characteristics of the study population are shown in Table 1,
while the procedural data are listed in Table 2.
What’s new?
† This is the first multicentre study specifically aimed at collect-
ing data regarding the incidence of complications with per-
manent sequelae in an unselected population of patients
undergoing catheter ablation for atrial fibrillation by means
of open-irrigated catheters.
† No procedure-related death was reported. Out of a cumula-
tive complication rate of 3.7%, only 0.2% of the patients devel-
oped permanent sequelae.
† Complications were more frequent when catheter ablation
was performed in females and by less experienced operators.
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Complications
No procedure-related death was observed. Complications occurred
in 81patients (3.7%): 46patients (2.1%) sufferedvascular access com-
plications; 13 patients (0.6%) developed cardiac tamponade, success-
fully drained in all the cases; six patients (0.3%) had arterial
thromboembolism (four transient ischaemic attack and two ischae-
mic strokes); five patients (0.2%) presented pericardial effusion not
requiring specific intervention; three patients (0.1%) had phrenic
nerve paralysis during right PV isolation; three patients (0.1%) had
pericarditis; three patients (0.1%) had haemothorax requiring drain-
age in two cases. Other isolated but serious adverse events were
documented in two patients (0.1%): haemorrhagic stroke in one;
transient ST elevation in one.
In Table 3, clinical and procedural characteristic of patients
with and without complications are shown. At univariate analysis,
patients with complications were older and more frequently
females, and the ablation was less frequently performed by the
experienced operators. At multivariate analysis, female gender
[odds ratio (OR) 2.5, CI: 1.5–3.7, P, 001] predicted compli-
cations, while higher operator experience (OR 0.5, CI: 0.4–0.7,
P, 001) inversely related to complications.
Complications with permanent sequelae
In five patients (0.2%) a complication with a permanent sequelae was
observed: three permanent neurological sequelae (two ischaemic
and one haemorrhagic stroke), and two permanent symptomatic
phrenic nerve palsy. Clinical and procedural characteristics of
patients with permanent complications are presented in Table 4.
Discussion
Main findings
This is the first multicentre study specifically aimed at collecting data
regarding the incidence of complications with permanent sequelae in
an unselected population of patients undergoing CA for AF by means
of OIC. No procedure-related death was reported. Out of a cumula-
tive complication rate of 3.7%, only 0.2% of patients developed per-
manent sequelae. Complications were more common when CA was
performed in females and by less experienced operators.
Complications in catheter ablation for
atrial fibrillation
The demonstration of superiority of CA over antiarrhythmic therapy
in the management of several settings of AF patients3 – 5 has greatly
increased the procedure of AF CA in the last decade.19,20 Despite
technological improvements, CA of AF is still affected by a high
amount of complications mainly related to the extension of lesions
in the left atrium, the need of a deep anticoagulation, and the increas-
ing number of centres starting to approach AF ablation.12,17,21
Thrombo-embolic complications seem to be affected by ablation
technologies and by energy.22,23 In particular, OICs have been
reported to reduce the risk of thrombus formation at the elec-
trode–tissue interface, and the risk of steam pop.24 On the other
hand, OICs deliver a large amount of saline solution during prolonged
ablation procedures, and make deeper and larger lesions that might
increase the risk of pericardial effusion or perforation.
Our study is the first to be designed to evaluate the complications
during radiofrequency CA for AF by means of OICs, with an overall
complication rate of 3.7%, slightly lower than that reported by recent
multicentre studies using different technologies.12,18,21 Also, the rate
of thrombo-embolic complications (0.3%) and pericardial effusion or
Table 2 Procedural data of the 2167 enroled patients
Pre-ablation imaging (%)
MRI 13.0
CT 22.0
TEE 49.0
Mapping system (%)
None 7.0
CARTO 56.9
NavX 36.0
Other 0.1
Number of vascular accesses 3.0 (3–5)
Number of transseptal punctures 1 (1–1)
Number of ablated PVs 4 (4–4)
CTI ablation (%) 19.2
Mitral to inferior left PV isthmus ablation (%) 40.3
Left atrial roof ablation (%) 43.1
Duration of fluoroscopy exposure (minutes)a 22 (13–43)
Duration of RF delivery (minutes)b 31 (24–39)
Ongoing warfarin (%) 6.0
Learning curve level (%)
≤100 patients 6.0
101–500 patients 22.0
≥501 patients 70.0
Continuous variables are presented as mean (SD) or median (25–75 percentiles).
aAnalysis based on 1920 subjects.
bAnalysis based on 1775 subjects.
MRI, magnetic resonance imaging; CT, computed tomography; CTI, cavotricuspid
isthmus; LA, left atrium; PV, pulmonary vein; RF, radiofrequency; TEE,
transoesophageal echocardiography.
Table 1 Baseline clinical characteristics of the 2167
enroled patients
Male gender (%) 74.8
Age (years) 60 (52–67)
Duration of AF history (years) 3.0 (2–6)
Arrhythmic profile (%)
Paroxysmal AF 52.0
Persistent AF 27.3
Permanent AF 20.7
CHADS2 score 1 (0–1)
Mean left atrial diameter (mm) 42.0 (40–46)
Mean left ventricular ejection fraction (%) 57.4 (6.7)
Continuous variables are presented as mean (SD) or median (25–75 percentiles).
AF, atrial fibrillation; REDO, patients who had already undergone PV catheter
ablation.
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cardiac tamponade (0.8%) seems to confirm the safety of OICs, as
recently reported.14,16,17
We found an increase of complication rate when procedures were
performed by less experienced operators. This finding is consistent
with the observation that the operators’ experience and the hospital
volume related to better outcomes.12,21
Complications with permanent sequelae
The more feared complications of CA are obviously those leading to
death or to permanent sequelae.13 In the present study, only a 0.2% of
permanent sequelae was reported. Two of these were permanent
symptomatic phrenic nerve palsy occurred during ablation of the
right PVs. Impedance monitoring, and strict monitoring of phrenic
nerve function by means of regular pacing of the nerve, from the su-
perior vena cava and the left atrium, before ablation, are crucial to
avoid this complication, and should become mandatory during abla-
tion especially of the right PVs.
Two out of five permanent complications were related to embolic
events. This observation underlines once again the need of an aggres-
sive procedural and peri-procedural anticoagulation regimen. In par-
ticular, maintaining an ACT value ≥350 ms during ablation, and
performing the procedure on warfarin have been effective in redu-
cing such complications.25 However, some embolic events may
have been caused by thermally induced blood clots and this phenom-
enon is totally unresponsive to anticoagulation.
Previous registries12,13,21 have reported a rate of death ranging
from 0.1 to 0.46%. Although the low rate of death could require
larger study populations to assess its true incidence, the lack of
procedure-related death observed in our study further supports
the safety of OICs.
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Table 3 Univariate analysis for comparisons between patients with and without complications
No complicationsN 5 2084 ComplicationsN 5 81 P
Age (years) 60 (53–66) 64 (60–68) 0.03
Male gender (%) 72.7 53.1 ,0.001
CHADS2 score 1 (0–1) 1 (0–1) 0.49
Arrhythmic profile (%)
Paroxysmal 51.7 61.7 0.50
Persistent 27.6 21.0
Permanent 20.7 17.3
Duration of AF history (years) 4 (2–6) 3 (2–5) 0.12
Mean left atrial diameter (mm) 41 (40–45) 42 (40–45) 0.25
Left ventricular ejection fraction ,55% (%) 18.0 14.8 0.27
Pre-ablation imaging (%)
TEE 49.0 44.4 0.36
MRI 13.0 8.6
CT 23.3 28.4
ICE (%) 12.7 16.0 0.67
Mapping system (%)
None 7.1 6.2 0.92
CARTO 56.9 55.5
NavX 35.9 38.3
Other 0.1 0
Number of vascular accesses 3 (3–5) 3 (3–4) 0.34
Number of transseptal punctures 1 (1–1) 1 (1–1) 0.38
Number of isolated PV 4 (4–4) 4 (4–4) 0.73
CTI ablation (%) 19.1 21.0 0.68
Mitral to inferior isthmus ablation (%) 40.6 33.3 0.19
Left atrial roof ablation (%) 43.4 34.6 0.11
Duration of fluoroscopy exposure (minutes) 21 (13–41) 33 (14–49) 0.23
Duration of RF delivery (minutes) 30 (24–40) 33 (24–38) 0.11
Ongoing warfarin (%) 5.7 6.1 1.0
Learning curve level (%)
,100 patients 5.7 11.1 ,0.001
101–500 patients 21.5 35.8
.501 patients 72.8 53.1
MRI, magnetic resonance imaging; CT, computed tomography; CTI, cavotricuspid isthmus; LA, left atrium; PV, pulmonary vein; RF, radiofrequency; TEE, transoesophageal
echocardiography.
Low incidence of permanent complications during CA for AF using OIC 1157
Downloaded from https://academic.oup.com/europace/article-abstract/16/8/1154/548749
by Biblioteca IRCCS Centro Cardiologico Monzino - Milano user
on 28 December 2017
Limitations
Unfortunately, we did not have a control group of patients undergo-
ing CAwith different technologies, such as cryoablation or multielec-
trode catheters associated with duty-cycled radiofrequency energy.
For this reason, any conclusion on the superiority of one tool over
the others can be derived from the present study. However, the
safety profile of the OICs seems to be evident when comparing the
present to the previously published data.
By study design, data collection focused on complications occur-
ring within 1 month after ablation: some rare but feared complica-
tions like PV stenosis and late pericardial tamponade could be
under-represented.
Clinical implications
Complications with permanent sequelae in CA for AF with the use of
OICs are very rare and in 40% of the cases related to embolic events.
Based on this evidence, it becomes acceptable to pay attention to a
higher potential risk of haemorrhagic events to reduce dreadful cere-
bral embolic complications, particularly in females. The overall rate of
complications of CA for AF by means of OICs is below 4%, but the
hazard is increased when CA is performed by less experienced
operators raising once again the issue of recommending a volume
threshold to enhance the safety of the procedure.
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Left superior pulmonary vein ectopic rhythmmimicking normal
sinus rhythm
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A 45-year-old man underwent pulmonary vein
(PV) isolation for paroxysmal atrial fibrillation.
Two alternating regular rhythms were recorded
at the left superior PV (LSPV—Panel A). The dom-
inant rhythm had a cycle length (CL) of 672 ms,
with an initial near-field electrogram (EGM) and
circumferential distribution (†) that preceded
the P-wave by 40 ms (earliest activation on
bipoles 1–2 and 19–20), followed by a far-field
EGM (*). During the second rhythm (CL of
839 ms), the near-field component demonstrated
the earliest activation on bipoles 9–10 and pre-
ceded P-wave by 73 ms (‡). Differential pacing
confirmed the LSPV origin. While coronary sinus
pacing demonstrated synchronous activation, left
atrial appendage (LAA)pacing showed reversal ac-
tivation (Panel B). Once isolation was achieved a
change was observed in P-wave (Panel C). A
stable dissociated PV rhythm was observed up to
60 min post-LSPV isolation.
Subtle differences in the P-wave can be appre-
ciated, during the ectopic rhythm the P-wave
axis was more rightward, with a morphology
that was consistent with a posterior left atrial
(LA) origin. Electrogram interpretation and differ-
ential pacing were required to differentiate a focal
PV source from a posterior LA or LAA origin.
The full-lengthversionof this report canbeviewed
at: http://www.escardio.org/communities/EHRA/publications/ep-case-reports/Documents/Left-superior-pulmonary.pdf.
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